Differential and Opposing Regulation of PAI-1 Promoter Activity by Estrogen Receptor α and Estrogen Receptor β in Endothelial Cells
- 6 August 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 95 (3) , 269-275
- https://doi.org/10.1161/01.res.0000136521.70093.f1
Abstract
To investigate the molecular mechanisms involved in the estrogen-dependent control of plasminogen activator inhibitor-1 (PAI-1) gene expression in vascular cells, we compared the transactivation properties of estrogen receptors (ERα and ERβ) in regulating the activity of a human PAI-1 promoter reporter construct in transfected bovine aortic endothelial cells (BAECs). ERα increased PAI-1 promoter activity in BAECs by an estrogen-dependent mechanism, whereas ERβ suppressed PAI-1 promoter activity by an estrogen-independent mechanism. The suppressive activity of ERβ was dominant over the inductive activity of ERα. Mutation of a putative estrogen response element (ERE) located at position −427 in the proximal promoter abolished the ERα action without influencing the suppressive effects of ERβ. Mutation of either AP1-like site did not eliminate the ERα or ERβ actions at the PAI-1 promoter, suggesting that other promoter elements are involved in these responses. These mutations significantly reduced the −3.4kbp PAI-1 promoter response to serum. We concluded that ERα and ERβ exert differential effects on the PAI-1 promoter activity in transfected BAECs. ERα activated the PAI-1 promoter through a proximal ERE (−427) and possibly additional EREs located within the PAI-1 promoter, whereas ERβ suppressed the promoter construct via an unidentified mechanism. This is the first demonstration of the differential regulation of a vascular gene promoter by ERα and ERβ.Keywords
This publication has 34 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapyCancer, 2001
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Estrogen Increases Endothelial Nitric Oxide by a Receptor Mediated SystemBiochemical and Biophysical Research Communications, 1995
- Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.Journal of Clinical Investigation, 1995
- A common response element mediates differential effects of phorbol esters and forskolin on type‐1 plasminogen activator inhibitor gene expression in human breast carcinoma cellsEuropean Journal of Biochemistry, 1994
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- A general method applicable to the search for similarities in the amino acid sequence of two proteinsJournal of Molecular Biology, 1970